Inactive Instrument

Insiders Jounce Therapeutics, Inc.

Equities

JNCE

US4811161011

Insiders

Unlock all the news: Be the first to know and act before the market!

Graphite Bio, Inc. Announces Executive Changes	23-08-23	CI
Jounce Therapeutics, Inc. Announces Board Changes	23-05-04	CI
Jounce Therapeutics, Inc. Expects Resignation of Elizabeth Trehu as Chief Medical Officer	23-03-30	CI
Jounce Therapeutics, Inc. Announces Resignation of J. Duncan Higgons from the Board of Directors and All Committees Thereof, Effective as December 31, 2022	22-12-20	CI
Jounce Therapeutics, Inc. Announces Executive Promotions	22-08-04	CI
Jounce Therapeutics, Inc. Announces Board Changes	21-09-15	CI
Insider Trends: Insider Prolongs 90-Day Selling Trend at Jounce Therapeutics	21-05-27	MT
Jounce Therapeutics, Inc. Appoints Dmitri Wiederschain as Chief Scientific Officer	21-04-12	CI
Jounce Therapeutics Appoints Luisa Salter-Cid, to Its Board of Directors	21-02-12	CI
Insider Trends: Insider Prolongs 90-Day Selling Trend at Jounce Therapeutics	21-01-11	MT
Insider Trends: 90-Day Insider Selling Trend Prolonged at Jounce Therapeutics	20-11-23	MT
Insider Trends: Jounce Therapeutics Insider Extends 90-Day Selling Trend	20-11-19	MT
Jounce Therapeutics, Inc. Appoints Robert Iannone to its Board of Directors	20-01-23	CI
Jounce Therapeutics Names Jacquelyn Fahey Sandell as Chief Legal Officer and Corporate Secretary	19-09-17	CI
Jounce Therapeutics, Inc Announces Board Changes	19-04-22	CI
Jounce Therapeutics, Inc. Appoints Luis A. Diaz to its Board of Directors	17-10-23	CI
Jounce Therapeutics Names Hugh Cole as Chief Business Officer and Head of Corporate Development	17-08-15	CI
Jounce Therapeutics, Inc. Appoints Stephen Farrand as Chief Technical Officer	16-09-26	CI
Jounce Therapeutics, Inc. Appoints Barbara G. Duncan to its Board of Directors	16-05-25	CI
Jounce Therapeutics Appoints Perry Karsen to its Board	16-01-21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Jounce Therapeutics, Inc.

Equities

JNCE

US4811161011

Insiders

Filters